Rheumatology Advance Access originally published online on October 17, 2008
Rheumatology 2009 48(3):210-212; doi:10.1093/rheumatology/ken394
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
EDITORIALS |
Vitamin D and autoimmune rheumatic diseases
1Research Laboratories and Clinical Academic Unit of Rheumatology, University of Genova, Genova, Italy
Correspondence to: M. Cutolo, Research Laboratories and Clinical Academic Unit of Rheumatology, University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy. E-mail: mcutolo@unige.it
| The first 150 words of the full text of this article appear below. |
Introduction
Vitamin D is classified as a secosteroid in which one of the rings has been broken, in this case by ultraviolet B sunlight, and the main source of vitamin D is de novo synthesis in the skin. Although vitamin D is consumed in food, dietary intake alone is often insufficient, supplying only 20% of the body's requirements.
In recent years, the discovery of the vitamin D receptor (VDR) in the cells of the immune system and the fact that several of these cells produce the vitamin D hormone suggested that it could have immunoregulatory properties.
However, vitamin D insufficiency is emerging as a clinical problem of global proportions and epidemiology has linked vitamin D status with autoimmune disease susceptibility and severity [1].
Therefore, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] the biologically active metabolite of Vitamin D3, not only regulates bone and calcium metabolism but also exerts
The mechanisms of vitamin D immunomodulation
Vitamin D and autoimmune rheumatic diseases
RA
SLE
Conclusions
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. VACCA, C. CORMIER, M. PIRAS, A. MATHIEU, A. KAHAN, and Y. ALLANORE Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis J Rheumatol, September 1, 2009; 36(9): 1924 - 1929. [Abstract] [Full Text] [PDF] |
||||
